Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
DXCM DexCom, Inc. daily Stock Chart
DXCM [NASD]
DexCom, Inc.
Healthcare | Medical Laboratories & Research | USA
statements
Index- P/E- EPS (ttm)-1.94 Insider Own0.80% Shs Outstand91.50M Perf Week0.54%
Market Cap21.56B Forward P/E124.92 EPS next Y1.89 Insider Trans-23.69% Shs Float91.12M Perf Month10.39%
Income-171.70M PEG- EPS next Q0.72 Inst Own- Short Float5.50% Perf Quarter56.14%
Sales1.35B P/S15.95 EPS this Y-324.80% Inst Trans0.04% Short Ratio4.98 Perf Half Y54.03%
Book/sh8.37 P/B28.15 EPS next Y33.47% ROA-8.40% Target Price240.19 Perf Year60.78%
Cash/sh15.63 P/C15.08 EPS next 5Y78.30% ROE-24.60% 52W Range107.44 - 242.14 Perf YTD7.71%
Dividend- P/FCF423.52 EPS past 5Y-28.10% ROI-11.10% 52W High-2.70% Beta0.80
Dividend %- Quick Ratio5.30 Sales past 5Y45.20% Gross Margin63.30% 52W Low119.29% ATR7.25
Employees2800 Current Ratio5.60 Sales Q/Q48.60% Oper. Margin-9.20% RSI (14)62.87 Volatility2.75% 3.03%
OptionableYes Debt/Eq1.39 EPS Q/Q-3.10% Profit Margin-12.70% Rel Volume0.58 Prev Close235.54
ShortableYes LT Debt/Eq1.39 EarningsFeb 13 AMC Payout- Avg Volume1.01M Price235.60
Recom1.60 SMA203.70% SMA506.77% SMA20044.24% Volume581,200 Change0.03%
Nov-07-19Upgrade Guggenheim Neutral → Buy
Nov-07-19Reiterated Canaccord Genuity Buy $185 → $195
Oct-23-19Initiated Stifel Buy
Nov-28-18Initiated UBS Neutral $135
Oct-19-18Upgrade Goldman Sell → Neutral
Sep-12-18Upgrade Northland Capital Under Perform → Market Perform
Aug-02-18Reiterated Canaccord Genuity Buy $105 → $125
Jul-02-18Upgrade Raymond James Mkt Perform → Outperform
Jun-08-18Upgrade JP Morgan Neutral → Overweight
May-11-18Initiated BofA/Merrill Buy $100
May-03-18Reiterated Canaccord Genuity Buy $81 → $85
Apr-04-18Initiated Guggenheim Neutral
Apr-04-18Initiated Goldman Sell $57
Mar-23-18Upgrade Robert W. Baird Neutral → Outperform
Jan-04-18Downgrade Northland Capital Market Perform → Under Perform
Sep-28-17Reiterated Wedbush Outperform $85 → $76
Sep-28-17Downgrade Raymond James Outperform → Mkt Perform
Sep-28-17Downgrade Northland Capital Outperform → Market Perform
Sep-28-17Downgrade JP Morgan Overweight → Neutral
Sep-26-17Initiated Northland Capital Outperform $85
Jan-23-20 05:55PM  Best Thematic ETF for 2020: Cloud, Internet of Things & More Zacks
10:45AM  Will New Buyouts Aid Quest Diagnostics (DGX) Q4 Earnings? Zacks
09:17AM  Will Segmental Growth Aid Hologic (HOLX) in Q1 Earnings? Zacks
08:46AM  What's in Store for Varian Medical (VAR) in Q1 Earnings? Zacks
Jan-22-20 08:36AM  Stryker (SYK) to Report Q4 Earnings: What's in the Cards? Zacks
07:38AM  Here's Why You Should Add DexCom (DXCM) to Your Portfolio Zacks
Jan-21-20 09:00AM  Here's Why You Should Add Veeva (VEEV) to Your Portfolio Now Zacks
09:00AM  Dexcom Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for February 13, 2020 at 4:30 p.m. Eastern Time Business Wire
Jan-17-20 12:00PM  Here's Why DexCom (DXCM) is a Great Momentum Stock to Buy Zacks
09:15AM  Dentsply (XRAY) Soars to 52-Week High, Time to Cash Out? Zacks
08:27AM  Diabetes Management Gains FDA Attention: 3 Stocks in Focus Zacks
Jan-16-20 10:14AM  Nevro (NVRO) Gains Ground on Solid Preliminary Q4 Results Zacks
08:40AM  Allscripts Expands Partnership With PIH Health Through 2025 Zacks
Jan-15-20 07:32AM  Inogen (INGN) Announces Preliminary Q4 Results, Slashes View Zacks
Jan-14-20 05:50PM  DexCom (DXCM) Dips More Than Broader Markets: What You Should Know Zacks
07:22AM  ABIOMED (ABMD) Announces Preliminary Q3 Results, Slashes View Zacks
Jan-13-20 09:11AM  Dexcom Rebounds Investor's Business Daily Video
07:30AM  Dexcom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2019 and Provides Initial 2020 Outlook Business Wire
Jan-11-20 08:00AM  These Four Stocks Are In Buy Range Before Key Healthcare Conference Investor's Business Daily
Jan-10-20 04:19PM  IBD Stock Of The Day Dexcom Is Breaking Out To A Record High Here's Why Investor's Business Daily
08:19AM  Here's Why You Should Add Cerner (CERN) to Your Portfolio Zacks
Jan-09-20 07:06AM  Here's Why You Should Hold on to AngioDynamics Stock Now Zacks
Jan-08-20 05:45PM  DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know Zacks
02:24PM  Walgreens Boots (WBA) Q1 Earnings Lag Estimates, Margins Fall Zacks
12:00PM  Spiros Segalas Adds 4 Stocks to Portfolio in 4th Quarter GuruFocus.com
11:30AM  Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year? Zacks
09:15AM  DexCom (DXCM) Hits Fresh High: Is There Still Room to Run? Zacks
09:02AM  AngioDynamics (ANGO) Q2 Earnings Top, Revenues Lag Estimates Zacks
08:19AM  Dow Jones Futures Erase Huge Iran Missile Attack Losses As Trump Says 'All Is Well' Investor's Business Daily
Jan-07-20 06:16PM  Dow Jones Futures: Stock Market Rally Pauses Amid Iran Fears, But Micron Leads 5 'Live' Winners Investor's Business Daily
12:23PM  Dexcom Earns Membership In 95-Plus Composite Rating Club Investor's Business Daily
08:09AM  Dow Jones Futures: Key Sector Rejoins Stock Market Rally; These 6 Stocks Just Entered Buy Zones Investor's Business Daily
Jan-06-20 08:45AM  Dexcom to Present at 38th Annual J.P. Morgan Healthcare Conference Business Wire
Jan-03-20 06:13PM  Wilsonville device maker appeals ruling in patent suit American City Business Journals
08:37AM  Here's Why You Should Hold on to Becton, Dickinson Stock Now Zacks
Jan-02-20 10:00AM  Top-Ranked ETFs, Stocks From Top Sector of the Last Decade Zacks
08:34AM  3 Healthcare Stocks Primed for 2020 Gains TipRanks
Dec-31-19 07:49AM  Here's Why You Should Hold on to Intuitive Surgical for Now Zacks
Dec-30-19 08:32AM  Here's Why You Should Invest in Patterson Companies Stock Now Zacks
Dec-27-19 10:04AM  Here's Why You Should Retain OPKO Health (OPK) Stock for Now Zacks
Dec-26-19 11:25AM  Hedge Fund Consensus Stocks vs. DexCom, Inc. (DXCM) In 2019 Insider Monkey
Dec-24-19 09:02AM  6 MedTech Stocks That are Set to Beat the Market in 2020 Zacks
Dec-23-19 11:30AM  Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? Zacks
09:30AM  Dexcom Partners With Tandem Diabetes Care on the t:slim X2 Insulin Pump in the UK, Sweden, Italy and Spain PR Newswire
Dec-18-19 09:28AM  Here's Why You Should Add DexCom (DXCM) to Your Portfolio Zacks
Dec-16-19 06:45AM  Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System PR Newswire
Dec-12-19 05:46PM  DocuSign Leads 3 Standouts On 'Exceedingly Bullish' CAN SLIM Hedge Fund Manager's Watch List Investor's Business Daily
Dec-11-19 06:29AM  Is DexCom's (NASDAQ:DXCM) Share Price Gain Of 287% Well Earned? Simply Wall St.
Dec-06-19 02:46PM  No more finger prick? Md. biotech aims for bigger market for diabetes app. American City Business Journals
11:31AM  DexCom (DXCM) Up 16.5% Since Last Earnings Report: Can It Continue? Zacks
Dec-05-19 11:30AM  Has DexCom (DXCM) Outpaced Other Medical Stocks This Year? Zacks
Dec-04-19 10:38AM  Should You Buy DexCom, Inc. (DXCM)? Insider Monkey
Dec-03-19 08:07AM  Dow Jones Futures Fall As Trump Says He Might Favor China Trade Deal After 2020 Election Investor's Business Daily
06:48AM  Dow Jones Futures Fall As Trump Says China Trade Deal Might Wait Until After 2020 Election Investor's Business Daily
Dec-02-19 11:28AM  DXCM Closes Strong Investor's Business Daily Video
10:04AM  The Zacks Analyst Blog Highlights: DexComm, Forterra, Vista Outdoor, Hibbett Sports and Target Zacks
01:19AM  PRESS DIGEST- Wall Street Journal - Dec 2 Reuters
Nov-29-19 05:09PM  5 Screaming Hot Strong Buy Stocks Zacks
10:59AM  DexCom, Inc. (DXCM) Shares March Higher, Can It Continue? Zacks
10:36AM  Top Ranked Momentum Stocks to Buy for November 29th Zacks
10:11AM  5 Best Bets in View Before the Curtain Falls on November Zacks
07:43AM  6 Top Momentum Stocks in November With More Room to Run Zacks
Nov-28-19 08:14AM  Digital Diabetes Management Gains Momentum: 3 Stocks in Focus Zacks
Nov-27-19 10:10AM  Can DexCom Trade Still Higher or Did We Witness a Blow Off? TheStreet.com
08:21AM  The Zacks Analyst Blog Highlights: DexCom, Forterra, NeoPhotonics, Ironwood and Cardtronics Zacks
Nov-26-19 09:36AM  5 Best-Performing, Top-Ranked Growth Stocks of November Zacks
09:00AM  Dexcom Announces Upcoming Conference Presentation TEST Business Wire Releases
09:00AM  Dexcom Announces Upcoming Conference Presentation Business Wire
08:24AM  5 Growth Stocks to Buy as U.S.-China Trade Tiff Eases Zacks
Nov-25-19 09:17AM  MEDNAX (MD) Ties Up With Homestead to Expand in Florida Zacks
08:37AM  Dexcom (DXCM) Hits a 52-Week High: What's Driving the Stock? Zacks
Nov-21-19 08:21AM  Digital Health Gaining Momentum: 3 MedTech Stocks in Focus Zacks
Nov-20-19 10:20AM  Earnings Estimates Moving Higher for DexCom (DXCM): Time to Buy? Zacks
09:49AM  The Zacks Analyst Blog Highlights: comScore, Communications Systems, Vista Outdoor, Forterra and DexCom Zacks
Nov-19-19 10:24AM  5 Winning Stocks Halfway Through Q4 Zacks
Nov-18-19 08:08AM  BD's Onclarity HPV PMA Submission to Boost Women's Health Zacks
Nov-15-19 09:38AM  San Gorgonio Hospital Picks Allscripts Sunrise Community Care Zacks
Nov-14-19 01:50PM  Growth Stocks And How To Find Big Stock Market Winners: Try This Blue Dot List In MarketSmith Investor's Business Daily
01:31PM  Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks Zacks
10:38AM  5 Companies Hit 52-Week Highs GuruFocus.com
08:08AM  NextGen's Medfusion Buyout to Improve Patient Experience Zacks
03:19AM  Dexcom Looks Poised to Build on Its Big Gap Up TheStreet.com
Nov-13-19 06:04AM  5 Relative Price Strength Stocks to Buy for Optimum Returns Zacks
01:25AM  Edited Transcript of DXCM earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-12-19 09:30AM  Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? Zacks
08:14AM  The Zacks Analyst Blog Highlights: Dexcom, Fortinet and Agnico Eagle Zacks
Nov-11-19 10:00AM  What Makes DexCom (DXCM) a Strong Momentum Stock: Buy Now? Zacks
Nov-08-19 09:25AM  DexCom (DXCM) Soars to 52-Week High, Time to Cash Out? Zacks
09:11AM  DexCom (DXCM) Earnings and Revenues Beat Estimates in Q3 Zacks
09:00AM  Dexcom Announces Upcoming Conference Presentation Business Wire
08:14AM  The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut Benzinga
Nov-07-19 04:39PM  IBD Stock Of The Day Breaks Out To Record High After Crushing Earnings Views Investor's Business Daily +27.16%
01:59PM  Dow Jones Soars 858 Points In Q4; Why This Market Leader Surpassed An Alternate Buy Point Investor's Business Daily
Nov-06-19 04:03PM  Dexcom Reports Third Quarter 2019 Financial Results Business Wire
Nov-01-19 10:23AM  DexCom (DXCM) to Report Q3 Earnings: What's in the Offing? Zacks
Oct-22-19 04:26AM  3 Under the Radar Growth Stocks Investopedia
Oct-15-19 01:25PM  DexCom Falls After Rival Tandem Teams With Abbott for Insulin Pump TheStreet.com
Oct-12-19 04:56PM  Here is What Hedge Funds Think About DexCom, Inc. (DXCM) Insider Monkey
09:55AM  Is DexCom (NASDAQ:DXCM) Weighed On By Its Debt Load? Simply Wall St.
Oct-10-19 08:00AM  Dexcom CEO Kevin Sayer Rallies Employees Around A Noble Mission Investor's Business Daily
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAYER KEVIN RPresident, CEO and ChairmanJan 13Sale230.626,0001,383,710196,937Jan 15 04:48 PM
Murphy Patrick MichaelSVP, Legal AffairsJan 09Sale235.01500117,50526,947Jan 10 08:03 PM
FOLETTA MARK GDirectorJan 03Sale218.051,000218,05315,147Jan 07 08:49 PM
SKYLER JAY SDirectorJan 03Sale217.8525,8065,621,81630,417Jan 07 08:50 PM
ALTMAN STEVEN RDirectorJan 02Sale218.332,500545,83446,304Jan 06 09:05 PM
Pacelli Steven RobertEVP Strategy and Corporate DevDec 23Sale213.171,532326,57677,687Dec 23 07:42 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerDec 23Sale213.021,533326,55813,778Dec 23 07:42 PM
AUGUSTINOS NICHOLASDirectorDec 16Sale206.141,812373,5265,042Dec 16 09:17 PM
KAHN BARBARADirectorDec 12Sale205.149,0001,846,22211,266Dec 16 09:16 PM
Murphy Patrick MichaelSVP, Legal AffairsDec 09Sale224.425,5181,238,34627,447Dec 10 08:42 PM
FOLETTA MARK GDirectorDec 03Sale227.591,000227,59316,147Dec 05 04:22 PM
SAYER KEVIN RPresident, CEO and ChairmanDec 02Sale221.3710,0002,213,684202,937Dec 04 08:04 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerNov 22Sale217.561,533333,51915,311Nov 25 07:43 PM
Pacelli Steven RobertEVP Strategy and Corporate DevNov 22Sale217.561,532333,30079,219Nov 25 07:42 PM
Abbey DonaldEVP Quality and Regulatory AffNov 21Sale220.2111,6042,555,32968,946Nov 25 06:20 PM
AUGUSTINOS NICHOLASDirectorNov 07Sale185.291,208223,8306,854Nov 08 08:58 PM
SAYER KEVIN RPresident, CEO and ChairmanNov 04Sale157.5010,0001,575,017212,937Nov 06 06:20 PM
Pacelli Steven RobertEVP Strategy and Corporate DevOct 23Sale152.371,532233,43580,751Oct 25 04:35 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerOct 23Sale152.341,533233,53016,844Oct 25 04:35 PM
SAYER KEVIN RPresident, CEO and ChairmanOct 01Sale149.6010,0001,496,001222,937Oct 03 06:40 PM
ALTMAN STEVEN RDirectorOct 01Sale149.172,500372,91648,804Oct 03 06:40 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerSep 24Sale155.002,016312,4820Sep 26 08:42 PM
Pacelli Steven RobertEVP Strategy and Corporate DevSep 23Sale155.471,532238,18182,283Sep 25 07:37 PM
Balo Andrew K*Sep 18Sale151.462,386361,38457,916Sep 19 06:46 PM
AUGUSTINOS NICHOLASDirectorSep 16Sale145.491,208175,7528,062Sep 18 06:03 PM
Blackford Quentin S.EVP Chief Financial OfficerSep 10Sale141.2510,3201,457,69169,754Sep 12 04:25 PM
Leach Jacob StevenEVP Chief Technology OfficerSep 09Sale149.864,712706,118111,105Sep 11 09:29 PM
Abbey DonaldEVP Quality and Regulatory AffSep 09Sale149.855,843875,59880,550Sep 11 09:30 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerSep 09Sale149.855,843875,59466,821Sep 11 09:28 PM
Murphy Patrick MichaelSVP Legal AffairsSep 09Sale149.862,495373,89732,965Sep 11 09:28 PM
Pacelli Steven RobertEVP Strategy and Corporate DevSep 09Sale149.865,843875,62083,815Sep 11 09:29 PM
SAYER KEVIN RPresident, CEO and ChairmanSep 09Sale149.8614,3222,146,269232,937Sep 11 09:27 PM
MOY JEFFREYSVP OperationsSep 09Sale149.854,601689,47534,869Sep 11 09:45 PM
Balo Andrew K*Sep 09Sale151.569,1071,380,23460,302Sep 11 09:42 PM
Blackford Quentin S.EVP Chief Financial OfficerSep 09Sale149.8611,6861,751,23280,074Sep 11 09:36 PM
ACE HEATHER SSVP Human ResourcesSep 09Sale151.226,415970,07352,676Sep 11 09:32 PM
SAYER KEVIN RPresident, CEO and ChairmanSep 03Sale170.1310,0001,701,274247,259Sep 05 04:16 PM
Balo Andrew K*Sep 03Sale170.00376,29069,409Sep 05 04:16 PM
ACE HEATHER SSVP Human ResourcesAug 23Sale174.807,2431,266,06259,091Aug 26 09:12 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerAug 23Sale175.142,016353,0882,016Aug 26 09:12 PM
SAYER KEVIN RPresident, CEO and ChairmanAug 15Sale156.1210,0001,561,167278,100Aug 19 06:20 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerJul 23Sale153.562,016309,5704,032Jul 24 06:15 PM
SAYER KEVIN RPresident, CEO and ChairmanJul 08Sale146.256,000877,476288,100Jul 09 06:57 PM
ALTMAN STEVEN RDirectorJul 01Sale151.622,500379,05251,304Jul 02 09:38 PM
Pacelli Steven RobertEVP Strategy and Corporate DevJun 24Sale149.653,116466,30489,658Jun 25 05:21 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerJun 24Sale149.622,016301,6266,048Jun 25 05:21 PM
AUGUSTINOS NICHOLASDirectorJun 14Sale146.321,208176,7559,270Jun 17 05:50 PM
Leach Jacob StevenEVP Chief Technology OfficerJun 13Sale145.325,099741,008115,781Jun 14 05:32 PM
Murphy Patrick MichaelSVP Legal AffairsJun 10Sale127.0340050,81235,460Jun 11 06:12 PM
SAYER KEVIN RPresident, CEO and ChairmanJun 10Sale132.746,000796,444294,100Jun 11 06:12 PM
Balo Andrew K*Jun 05Sale125.007,825978,12569,392Jun 06 05:35 PM
Abbey DonaldEVP Quality and Regulatory AffJun 03Sale121.089,0301,093,35286,393Jun 04 05:37 PM
Blackford Quentin S.EVP Chief Financial OfficerMay 29Sale118.958,8741,055,52791,740May 30 04:56 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMay 23Sale117.292,016236,4528,064May 24 05:09 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMay 23Sale116.713,597419,81692,774May 24 05:09 PM
FOLETTA MARK GDirectorMay 15Sale121.891,000121,89513,095May 17 06:22 PM
SAYER KEVIN RPresident, CEO and ChairmanMay 13Sale115.736,000694,365300,100May 14 06:47 PM
Murphy Patrick MichaelSVP Legal AffairsMay 10Sale116.9240046,76835,860May 13 05:51 PM
Leach Jacob StevenEVP Chief Technology OfficerApr 24Option Exercise7.274,79734,874120,880Apr 25 06:06 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerApr 23Sale116.982,016235,83810,080Apr 24 07:58 PM
Pacelli Steven RobertEVP Strategy and Corporate DevApr 23Sale116.613,596419,32996,371Apr 24 07:58 PM
FOLETTA MARK GDirectorApr 15Sale118.981,000118,97714,095Apr 17 05:20 PM
SAYER KEVIN RPresident, CEO and ChairmanApr 15Sale118.916,000713,471306,100Apr 16 05:37 PM
Murphy Patrick MichaelSVP Legal AffairsApr 10Sale115.0540046,02036,260Apr 12 05:50 PM
ALTMAN STEVEN RDirectorApr 01Sale119.602,500298,99950,355Apr 02 07:09 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMar 25Sale127.382,016256,78912,096Mar 27 05:40 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 22Sale140.043,596503,57199,967Mar 26 06:25 PM
FOLETTA MARK GDirectorMar 15Sale150.281,000150,27915,095Mar 19 06:24 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 12Sale142.7910,8111,543,726103,913Mar 13 07:01 PM
SAYER KEVIN RPresident, CEO and ChairmanMar 12Sale142.7926,5663,793,418312,100Mar 13 07:01 PM
Balo Andrew K*Mar 12Sale142.7910,9171,558,86277,217Mar 13 07:00 PM
Blackford Quentin S.EVP Chief Financial OfficerMar 12Sale142.795,358765,081100,614Mar 13 07:00 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMar 12Sale142.7910,8111,543,72672,570Mar 13 07:00 PM
Leach Jacob StevenEVP Chief Technology OfficerMar 12Sale142.798,5551,221,587116,083Mar 13 07:00 PM
MOY JEFFREYSVP OperationsMar 12Sale142.798,5311,218,16027,358Mar 13 07:01 PM
Murphy Patrick MichaelSVP Legal AffairsMar 12Sale142.793,962565,74336,660Mar 13 07:01 PM
Abbey DonaldEVP Quality and Regulatory AffMar 12Sale142.797,6531,092,78995,423Mar 13 06:59 PM
ACE HEATHER SSVP Human ResourcesMar 12Sale142.795,793827,19566,334Mar 13 07:00 PM
SAYER KEVIN RPresident, CEO and ChairmanMar 11Sale142.986,000857,890338,666Mar 13 07:01 PM
ACE HEATHER SSVP Human ResourcesMar 11Sale143.024,668667,63772,127Mar 13 07:00 PM
Murphy Patrick MichaelSVP Legal AffairsMar 08Sale141.5640056,62428,908Mar 11 08:46 PM
Pacelli Steven RobertEVP Strategy and Corporate DevFeb 22Sale144.671,667241,15799,737Feb 26 07:58 PM
FOLETTA MARK GDirectorFeb 15Sale148.721,000148,72316,095Feb 20 05:01 PM
SAYER KEVIN RPresident, CEO and ChairmanFeb 11Sale148.906,000893,400308,837Feb 13 07:23 PM
Murphy Patrick MichaelSVP Legal AffairsFeb 08Sale142.7640057,10429,308Feb 12 09:24 PM
Murphy Patrick MichaelSVP Legal AffairsFeb 08Sale142.7640057,10429,308Feb 12 04:46 PM
open in yahoo | open in reuters | open in google